CIDRAP newsletters options
A new report from the World Organisation for Animal Health (WOAH, formerly OIE) shows global use of antimicrobials in animals fell by 27% from 2016 through 2018.
Also, "Many individuals are presenting with atypical symptoms," the WHO says.
VRBPAC experts approved the booster recommendation by a 17-to-2 vote.
A new study from researchers at Boston University (BU) shows that, for all but 17% of healthy, vaccinated young adults, the infectious period for COVID-19 from the Delta and Omicron variants was 5 days. The study was recently published in Clinical Infectious Diseases.
As cases top 4,000 worldwide, WHO consultants take a wait-and-see approach.
The incidence dropped by one-fifth for both mRNA vaccines when dose spacing was longer.
The WHO says it has received reports of 920 probable cases from 33 countries.
Emergent BioSolutions said in a news release late last week that the US Food and Drug Administration (FDA) has accepted for review an adjuvanted version of its anthrax vaccine for post-exposure prophylaxis (prevention) of anthrax.
The Journal of Infectious Diseases has published studies demonstrating lower COVID-19 incidence—but a higher risk of severe disease—in people with Down syndrome (DS), and a lower COVID vaccine immune response.
An additional 600,000 lives might have been saved if global vaccination goals had been met.
The number of genetic substitutions is 6 times higher than expected for an orthopoxvirus.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
A study of adults discharged from more than 900 US hospitals in 2019 found that more than one-third received empiric gram-negative antibiotic therapy, with more than 1 in 5 receiving broad-spectrum antibiotics, researchers reported yesterday in Clinical Infectious Diseases.
A study yesterday in JAMA Internal Medicine shows that a fourth Pfizer COVID-19 vaccine dose provided 64% to 67% protection against hospitalization and 72% protection against death in nursing home residents, but only 34% protection against infection during an Omicron-dominated period.
The absolute risk appears to be only slightly higher than in uninfected peers.
Also, global experts meet to consider if the threat constitutes a global public health emergency.
Typhoid fever has become increasingly resistant to antibiotics over the past 50 years.
A study of Veterans Affairs (VA) patients found that the expectation of an antibiotic had a bigger impact on patient satisfaction than did receipt of an antibiotic, researchers reported today in Antimicrobial Stewardship & Healthcare Epidemiology.
Maternal COVID vaccination during pregnancy provides 52% protection against COVID-19 hospitalization in infants but only 38% protection against Omicron hospitalization, according to a study yesterday in the New England Journal of Medicine.
Protection against an intensive care unit (ICU) stay, however, was 70%.
Only 0.74% of patients visited an emergency department and only 0.11% a hospital.
